Pfizer partners with SA firm for African vaccine production

Pfizer vaccine
Pfizer vaccine

US giant, Pfizer, has signed an agreement with Biovac, a Cape Town-based biopharmaceutical firm, to establish a plant in that country which, when fully operational, will produce 100 million COVID-19 doses annually exclusively for Africa.

Biovac is a private public partnership between the Biovac Consortium and South Africa’s Department of Health.

In a statement this afternoon, officials from Pfizer and its German partner in the vaccines, BioNTech, said manufacturing of finished doses was expected to begin next year. Biovac’s Cape Town facility will be incorporated into the vaccine supply chain by the end of 2021 and Biovac will obtain drug substance from facilities in Europe.

Editor's Comment
Stakeholders must step up veggie supply

The Ministry of Agriculture, local producers, retailers, and industry associations must work together to overcome the obstacles hindering vegetable production and distribution.This collaborative approach is essential to improve the availability, quality, and affordability of vegetables in the market.Firstly, the Ministry of Agriculture should provide support and guidance to local farmers to enhance their productivity and efficiency. This could...

Have a Story? Send Us a tip
arrow up